Galapagos NV (GLPG)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

€26.40

Buy

€27.80

arrow-up€0.60 (+2.23%)

Prices updated at 19 Dec 2025, 16:37 CET

Prices minimum 15 mins delay

Prices in EUR

Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions.

FTSE EuroFirst 300

0.43%

Amsterdam

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	€27.70 - €26.64
	€32.74 - €20.00
	-
	1,776.59m
	-
	-
	141,840
	0.73
	117,198.74
	-0.08
	65.90m
	BE0003818359
	-6.62
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.